Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations

por Ondroušková, Eva, Bohúnová, Michaela, Závacká, Kristýna, Čech, Patrik, Šmuhařová, Petra, Boudný, Miroslav, Oršulová, Martina, Panovská, Anna, Radová, Lenka, Doubek, Michael, Plevová, Karla, Jarošová, Marie
Publicado 2022

IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K(δ) inhibitor idelalisib

por Sandova, Veronika, Pavlasova, Gabriela Mladonicka, Seda, Vaclav, Cerna, Katerina Amruz, Sharma, Sonali, Palusova, Veronika, Brychtova, Yvona, Pospisilova, Sarka, Fernandes, Stacey M., Panovska, Anna, Doubek, Michael, Davids, Matthew S., Brown, Jennifer R., Mayer, Jiri, Mraz, Marek
Publicado 2021

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes

por Olbertova, Helena, Plevova, Karla, Pavlova, Sarka, Malcikova, Jitka, Kotaskova, Jana, Stranska, Kamila, Spunarova, Michaela, Trbusek, Martin, Navrkalova, Veronika, Dvorackova, Barbara, Tom, Nikola, Pal, Karol, Jarosova, Marie, Brychtova, Yvona, Panovska, Anna, Doubek, Michael, Pospisilova, Sarka
Publicado 2022

Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene

por Poppova, Lucie, Pavlova, Sarka, Gonzalez, Beatriz, Kotaskova, Jana, Plevova, Karla, Dumbovic, Gabrijela, Janovska, Pavlina, Bystry, Vojtech, Panovska, Anna, Bezdekova, Lucie, Maslejova, Stanislava, Brychtova, Yvona, Doubek, Michael, Krzyzankova, Marcela, Borsky, Marek, Mayer, Jiri, Bryja, Vitezslav, Alonso, Sergio, Pospisilova, Sarka
Publicado 2022

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options

por Malcikova, Jitka, Pavlova, Sarka, Kunt Vonkova, Barbara, Radova, Lenka, Plevova, Karla, Kotaskova, Jana, Pal, Karol, Dvorackova, Barbara, Zenatova, Marcela, Hynst, Jakub, Ondrouskova, Eva, Panovska, Anna, Brychtova, Yvona, Zavacka, Kristyna, Tichy, Boris, Tom, Nikola, Mayer, Jiri, Doubek, Michael, Pospisilova, Sarka
Publicado 2021

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

por Salles, Gilles, Bachy, Emmanuel, Smolej, Lukas, Simkovic, Martin, Baseggio, Lucile, Panovska, Anna, Besson, Hervé, Healy, Nollaig, Garside, Jamie, Iraqi, Wafae, Diels, Joris, Pick-Lauer, Corinna, Spacek, Martin, Urbanova, Renata, Lysak, Daniel, Hermans, Ruben, Lundbom, Jessica, Callet-Bauchu, Evelyne, Doubek, Michael
Publicado 2019

COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group

por Šimkovič, Martin, Turcsányi, Peter, Špaček, Martin, Mihályová, Jana, Ryznerová, Pavlína, Maco, Mária, Vodárek, Pavel, Écsiová, Dominika, Poul, Hynek, Móciková, Heidi, Zuchnická, Jana, Panovská, Anna, Lekaa, Mohammad, Oršulová, Martina, Prchlíková, Adéla, Stejskal, Lukáš, Mašlejová, Stanislava, Brychtová, Yvona, Bezděková, Lucie, Papajík, Tomáš, Lysák, Daniel, Trněný, Marek, Smolej, Lukáš, Doubek, Michael
Publicado 2023

S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY

por Ondrisova, Laura, Seda, Vaclav, Hoferkova, Eva, Chiodin, Giorgia, Hlavac, Krystof, Kostalova, Lenka, Filip, Daniel, Faria Zeni, Pedro, Panovska, Anna, Plevova, Karla, Pospisilova, Sarka, Simkovic, Martin, Vrbacky, Filip, Lysak, Daniel, Fernandes, Stacey M., Davids, Matthew S., Maiques-Diaz, Alba, Charalampopoulou, Stella, Martin-Subero, Jose I, Brown, Jennifer R, Doubek, Michael, Forconi, Francesco, Mayer, Jiri, Mraz, Marek
Publicado 2023